Related Experiment Video
Updated: Feb 11, 2026

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
Nrf2-Mediated Metabolic Reprogramming in Cancer
Yan-Yang Wang1,2, Juan Chen3, Xiao-Ming Liu4
1Department of Radiation Oncology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China.
Abstract:
Metabolic reprogramming is one of the hallmarks of cancer. Nrf2 pathway is one of the critical signaling cascades involved in cell defense and survival against oxidative stress. The significance of Nrf2 in cancer metabolism begins to be recognized. In this minireview, we focus on the Nrf2-mediated cancer metabolic reprogramming and intend to highlight the role of Nrf2 in the regulation of malignant transformation, cancer proliferation, and the development of treatment resistance via metabolic adaptations. We hope for the development of noninvasive biomarkers and novel therapeutic approaches for cancer based on Nrf2-directed cancer metabolic reprogramming in the near future.
Insights
The Nrf2 pathway regulates cancer metabolism, influencing tumor growth and treatment resistance. Understanding this link may lead to new cancer biomarkers and therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Metabolic reprogramming is a key feature of cancer.
- The Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway is crucial for cellular defense against oxidative stress.
- Emerging evidence highlights the role of Nrf2 in cancer metabolism.
Purpose of the Study:
- To review the role of Nrf2 in cancer metabolic reprogramming.
- To highlight Nrf2's influence on malignant transformation, proliferation, and treatment resistance.
- To discuss potential future applications in cancer diagnostics and therapeutics.
Main Methods:
- Literature review of studies on Nrf2 and cancer metabolism.
- Analysis of Nrf2-mediated metabolic pathways in cancer.
- Synthesis of current knowledge on Nrf2's impact on cancer progression and therapy.
Main Results:
- Nrf2 significantly impacts cancer cell metabolism.
- Nrf2 activation promotes metabolic adaptations supporting cancer growth.
- Nrf2 plays a role in developing resistance to cancer treatments.
Conclusions:
- Nrf2-directed metabolic reprogramming is central to cancer development.
- Targeting Nrf2 offers potential for novel cancer therapies.
- Further research may yield noninvasive biomarkers for Nrf2-driven cancers.
More Related Videos
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Related Concept Videos
What is Metabolism?
Introduction to Nuclear Reprogramming
Methods of Nuclear Reprogramming
Receptor-mediated Endocytosis
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Somatic to iPS Cell Reprogramming